⚠️ Not investment advice. This is a quantitative research tool; every decision is the user's own responsibility. Past performance does not guarantee future results.⚠️ Not investment advice. Past performance does not guarantee future results.
MeridIAn Screener
Quantitative screener of 1,000+ companies · AI-assisted analysis · auditable virtual portfolio
ESEN
⚠️ Not investment advice. Past performance does not guarantee future results.
🔓 Sign up freeSee the full rankingSign in with Google
← Back to the full ranking · All companies

Lindt & Sprüngli LISP.SW

Switzerland Consumer Defensive
5.6/10
AI Analyst score
8,650.00 CHF
Last price at analysis date · analyst target 9,636.67 (+11.4%)
-27.0% (1 year)
📈 View on TradingView ↗
🛒 Where to buy LISP.SWPartner brokers · Switzerland · sample 200.00 € orderSwitzerland
XTBXTB1.00 €affiliate
Meridian is paid by these brokers at no extra cost to you; this is not investment advice. Public fee schedules · commission and FX, taxes excluded · Compare all 22 brokers by real cost →
No partner-broker fees for this market yet · Broker cost comparison →
🟡 HOLD — Hold; wait for European sales to stabilize and the real impact of GLP-1s to become clearer before taking a position.

Lindt & Sprüngli is a Swiss premium chocolate manufacturer, known for brands like Lindor, operating in the high-end confectionery segment globally. Lindt & Sprüngli maintains a strong brand moat (gross margin 61.99%) and a healthy balance sheet (Net Debt/EBITDA 1.22), but faces stagnant growth (revenue -0.20%), a guidance cut, and the structural threat of GLP-1 drugs on premium chocolate demand, justifying a cautious valuation despite its P/E of 27.32.

Financial health
7.0
Quality / Moat
4.9
Valuation
5.4
Growth
4.1
Dividend
6.3
Momentum
1.5
Risk & Context
8.1

Detailed metrics

Market and fundamental data as of the analysis date.

💵 Valuation
P/E27.32
Fwd P/E25.10
EV/EBITDA2.89
P/B0.45
P/S3.32
PEG0.34
Market cap19.76 B CHF
Enterprise value3.40 B CHF
🏰 Quality and moat
ROIC (approx.)1.4%
Gross margin61.99%
FCF conversion44%
Operating margin11.00%
📈 Profitability and margins
ROE15.94%
ROA7.32%
Net margin12.28%
FCF523.0 M CHF
FCF yield2.65%
🏦 Solvency and liquidity
Total debt1.85 B CHF
Net debt1.44 B CHF
Cash410.7 M CHF
EBITDA1.18 B CHF
Net debt / EBITDA1.22
D/E42.02
Current ratio1.78
Quick ratio0.77
🚀 Growth
Revenue growth-0.20%
Earnings growth4.10%
EPS (TTM)317.34 CHF
EPS (Fwd)344.58 CHF
💰 Dividend and risk
Dividend yield2.08%
Payout56.8%
Beta0.45
Analyst consensusunderperform (6)
Target price9,636.67 CHF
52-week range8,255.00 CHF – 13,360.00 CHF
⚠️ Main risk: The slowdown in growth in its key market (Europe) and the potential erosion of premium chocolate demand due to GLP-1 drug adoption, which has already led to a guidance cut.
See the full analysis and compare with the rest of the ranking →
📈 Full chart of LISP.SW on TradingView (affiliate link) · 🏦 Which broker to use? Cost comparison

Full AI report

Generated automatically from the metrics, the macro context and the company's news.

Lindt & Sprüngli is a Swiss premium chocolate manufacturer, known for brands like Lindor, operating in the high-end confectionery segment globally. Lindt & Sprüngli maintains a strong brand moat (gross margin 61.99%) and a healthy balance sheet (Net Debt/EBITDA 1.22), but faces stagnant growth (revenue -0.20%), a guidance cut, and the structural threat of GLP-1 drugs on premium chocolate demand, justifying a cautious valuation despite its P/E of 27.32.

Score by category

CategoryScore
Financial health7.0
Quality / Moat4.9
Valuation5.4
Growth4.1
Dividend6.3
Momentum1.5
Risk & Context8.1

OVERALL SCORE: 5.6/10

Context and risks

The macro context of rising rates does not materially affect Lindt due to its low leverage (Net Debt/EBITDA 1.22). The main risk is the structural trend of GLP-1 drugs on premium chocolate demand, mentioned in the news, and weakness in sales in its key market, Europe.

News considered in the analysis

  • Lindt falls as H1 Europe sales miss overshadows cost-led margin beat — Las ventas en Europa, su mercado principal, no cumplen expectativas, lo que pesa más que la mejora de margen por costes.
  • Lindt’s Price Hikes Start Melting — Las subidas de precios están perdiendo tracción, señal de que el poder de fijación de precios se debilita y el volumen podría sufrir.
  • Chocoladefabriken Lindt & Spruengli AG (LDSVF) Full Year 2025 Earnings Call Highlights: ... — Resumen de una llamada de resultados sin información nueva material para el análisis.
  • Lindt Guidance Cut Meets Emerging GLP 1 Premium Chocolate Demand Trend — Recorte de guidance y mención a la tendencia de los fármacos GLP-1, que podría afectar la demanda de chocolate premium a largo plazo.
  • Lindt Proves Premium Chocolate Still Has Bite — Artículo positivo que sugiere que la marca premium mantiene su atractivo, contrarrestando parcialmente las noticias negativas.

Verdict: Hold; wait for European sales to stabilize and the real impact of GLP-1s to become clearer before taking a position.

Main risk: The slowdown in growth in its key market (Europe) and the potential erosion of premium chocolate demand due to GLP-1 drug adoption, which has already led to a guidance cut.

Other Consumer Defensive companies

Neighbours in the sector ranking, to compare without going back to the index.

BungeBG5.7KrogerKR5.7CostcoCOST5.6DiageoDGE.L5.6MowiMOWI.OL5.6MetroMRU.TO5.6Associated British FoodsABF.L5.5KeskoKESKOB.HE5.5

See all 1,000+ companies in the index →

Automatically generated analysis from fundamental, market and news data. Not personalised financial advice — a research tool, not an individual recommendation. Past performance does not guarantee future results. Last update of this analysis: 2026-09-28. Legal notice, privacy & cookies.